Literature DB >> 20387135

Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program.

Ran Klein1, Jennifer M Renaud, Maria C Ziadi, Stephanie L Thorn, Andy Adler, Rob S Beanlands, Robert A deKemp.   

Abstract

BACKGROUND: Changes in myocardial blood flow between rest and stress states are commonly used to diagnose coronary artery disease. Relative myocardial perfusion imaging (MPI) is used routinely while myocardial blood flow quantification (MBF) may improve the sensitivity for detection of early disease. The ratio of flow at stress and rest (S/R) and their difference (S-R) have both been proposed as a means to detect regions with reduced myocardial flow reserve (MFR). In this study, we describe a highly automated method to calculate regional and global rest, stress, S/R, and S-R polar maps of the left ventricle myocardium.
METHODS: We measured the inter- and intra-operator variability using two randomized datasets (n = 30 each) for each of two operators (novice and expert) with correlation and Bland-Altman reproducibility coefficient (RPC%) analyses.
RESULTS: S-R MBF had less inter-operator dependent variability than S/R (RPC% = 5.0% vs 12.6%, P < .001). While there was no difference in intra-operator variability with S-R MBF (novice vs expert RPC% = 6.4% vs 5.9%, P = ns), variability was higher in the novice-operator for S/R (RPC% = 16.8% vs 8.5% respectively, P < .001), suggesting that S-R may be preferred for detecting small changes in MFR. The novice operator's intervention pattern became more similar to that of the expert in the later dataset, emphasizing the need for adequate training and quality assurance.
CONCLUSION: The proposed method results in low operator-dependent variability, suitable for routine use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20387135     DOI: 10.1007/s12350-010-9225-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  46 in total

1.  Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.

Authors:  Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 10.057

2.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

Authors:  G D Hutchins; M Schwaiger; K C Rosenspire; J Krivokapich; H Schelbert; D E Kuhl
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

3.  Some sources of error in measuring regional blood flow with radioactive microspheres.

Authors:  G D Buckberg; J C Luck; D B Payne; J I Hoffman; J P Archie; D E Fixler
Journal:  J Appl Physiol       Date:  1971-10       Impact factor: 3.531

4.  Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors.

Authors:  N A Mullani; R A Goldstein; K L Gould; S K Marani; D J Fisher; H A O'Brien; M D Loberg
Journal:  J Nucl Med       Date:  1983-10       Impact factor: 10.057

5.  Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography.

Authors:  T R DeGrado; M W Hanson; T G Turkington; D M Delong; D A Brezinski; J P Vallée; L W Hedlund; J Zhang; F Cobb; M J Sullivan; R E Coleman
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

6.  Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography.

Authors:  S Sawada; O Muzik; R S Beanlands; E Wolfe; G D Hutchins; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1995 Sep-Oct       Impact factor: 5.952

7.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.

Authors:  P Chareonthaitawee; P A Kaufmann; O Rimoldi; P G Camici
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

8.  Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis.

Authors:  Riikka Lautamäki; Richard T George; Kakuya Kitagawa; Takahiro Higuchi; Jennifer Merrill; Corina Voicu; Anthony DiPaula; Stephan G Nekolla; João A C Lima; Albert C Lardo; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

9.  Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET.

Authors:  Pilar Herrero; Joonyoung Kim; Terry L Sharp; John A Engelbach; Jason S Lewis; Robert J Gropler; Michael J Welch
Journal:  J Nucl Med       Date:  2006-03       Impact factor: 10.057

10.  Quantification of myocardial blood flow with 82Rb dynamic PET imaging.

Authors:  Mireille Lortie; Rob S B Beanlands; Keiichiro Yoshinaga; Ran Klein; Jean N Dasilva; Robert A DeKemp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-07       Impact factor: 9.236

View more
  53 in total

1.  Patient-centered imaging.

Authors:  E Gordon Depuey; John J Mahmarian; Todd D Miller; Andrew J Einstein; Christopher L Hansen; Thomas A Holly; Edward J Miller; Donna M Polk; L Samuel Wann
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

Review 2.  Quantification of myocardial blood flow and flow reserve: Technical aspects.

Authors:  Ran Klein; Rob S B Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 3.  Quantitative myocardial blood flow with Rubidium-82 PET: a clinical perspective.

Authors:  Christoffer E Hagemann; Adam A Ghotbi; Andreas Kjær; Philip Hasbak
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

Review 4.  Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM).

Authors:  Roberto Sciagrà; Alessandro Passeri; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Alessia Gimelli; Fabien Hyafil; Denis Agostini; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-05       Impact factor: 9.236

5.  Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET.

Authors:  Mireille Lortie; Jean N DaSilva; Miran Kenk; Stephanie Thorn; Darryl Davis; David Birnie; Rob S B Beanlands; Robert A deKemp
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

6.  The utility of 82Rb PET for myocardial viability assessment: Comparison with perfusion-metabolism 82Rb-18F-FDG PET.

Authors:  Jonathan B Moody; Keri M Hiller; Benjamin C Lee; Alexis Poitrasson-Rivière; James R Corbett; Richard L Weinberg; Venkatesh L Murthy; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2019-02-26       Impact factor: 5.952

7.  SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response.

Authors:  Michel Lalonde; David Birnie; Terrence D Ruddy; Robert A deKemp; Rob S B Beanlands; Richard Wassenaar; R Glenn Wells
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-09       Impact factor: 2.357

Review 8.  Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: A technical perspective.

Authors:  Jonathan B Moody; Benjamin C Lee; James R Corbett; Edward P Ficaro; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2015-04-14       Impact factor: 5.952

Review 9.  Proceedings of the Cardiac PET Summit, 12 May 2014, Baltimore, MD : 3: Quantitation of myocardial blood flow.

Authors:  Timothy M Bateman; K Lance Gould; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2015-04-24       Impact factor: 5.952

Review 10.  CFR and FFR assessment with PET and CTA: strengths and limitations.

Authors:  Ryo Nakazato; Ran Heo; Jonathon Leipsic; James K Min
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.